Zusammenfassung
Die histologische Einteilung wird nach der RYE-Klassifikation vorgenommen. Diese basiert ausschließlich auf morphologischen Kriterien, wobei zwischen 4 Subtypen unterschieden wird:
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Correa P, O’Connor GT (1971) Epidemiologic patterns of Hodgkin’s disease. Int J Cancer 8: 192–201
Glaser SL (1990) Hodgkin’s disease in black populations: A review of the epidemiologic literature. Sem Oncol 6: 643–659
Kaplan MS (1980) Hodgkin’s disease. Cambridge, Harvard University Press
Canellos GP, Propert K, Cooper R et al. (1988) MOPP vs ABVD vs MOPP alternating with ABVD in advanced Hodgkin’s disease: a prospective randomized CALGB trial. Proc A Soc Clin Oncol 7: 230
Diehl V, Pfreundschuh M, Löffler M et al. (1990) Cooperative trials of Hodgkin’s lymphoma in the Federal Republic of Germany. J Cancer Res Clin Oncol 116: 106–108
Diehl V, Pfreundschuh M, Löffler M et al. (1987) Results of the HD1 and HD3 trials of the German Hodgkin’s disease Study Group. Proc Amer Soc Clin Oncol 6: 204
Lathan B, Pfreundschuh M, Diehl V (1993) Therapiestrategien des Morbus Hodgkin. Internist 34: 146–154
Longo DL, Duffey PL, Young RC et al. (1992) Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin’s disease after combination chemotherapy: The low probability for cure. J Clin Oncol 10: 210–228
Pfreundschuh M, Koch P, Kuse R, Lathan B et al. (1991) Dexa-BEAM as salvage therapy for COPP + ABVD refractory Hodgkin’s disease: a phase II study of the German Hodgkin Study Group. Eur J Cancer 27 (Suppl 2): 237
Carella AM, Cartier P, Congiu A et al. (1991) Nine Year’s experience with ABMT in 128 patients with Hodgkin’s disease: an itatian study group report. Leukemia 5 (Suppl 1): 68–71
DeVita VT (1979) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73: 881–895
Morgenfeld M (1972) Treatment of malignant lymphoma with cyclophosphamide, vincristine, procarbazine and prednisone combination. XIV Internat Congr Hematolog Sao Paulo (abstract No 578 )
Bonadonna G (1975) Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastin and imidazole carboxamide versus MOPP. Cancer 36: 252–259
Klimo P, Connors JM et al. (1985) MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin’s disease. J Clin Oncol 3: 1174–1182
Connors JM, Klimo P, Adams et al. (1992) MOPP/AVB hybrid versus alternating MOPP/ABVD for advanced Hodgkin’s disease. Proc Am Soc Clin Oncol 11: 317
HD 5/6-Protokolle der Deutschen Hodgkin-Studiengruppe (Diehl V) 1988–1993
HD 8/9-Protokolle der Deutschen Hodgkin-Studiengruppe (Diehl V), aktiviert 2/1993
HDR1-Protokoll der Deutschen Hodgkin-Studiengnuppe (Diehl V, Schmitz N, Goldstone AH) aktiviert 2/1993
Rezidiv-Studienprotokoll der Deutschen Hodgkin-Studiengruppe (Diehl V, Pfreundschuh M), 1982–1985
Santoro A, Viviani S, Bonfante Vet al. (1987) CEP in Hodgkin’s disease resistent to MOPP and ABVD. Proc ASCO 6: 199
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lathan, B., Diehl, V. (1993). Morbus Hodgkin. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive